The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Mid-Year Review 2015 with RegeneRx Biopharmaceuticals, Inc. - Discusses Clinical Trials Programs in the Field of Ophthalmology

SNNLive caught up with J.J. Finkelstein, President & CEO of RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) at the 4th Annual SeeThruEquity MicroCap Investor Conference 2015 in New York City, NY.

Share With

Friday, July 17, 2015

   

© 2017 Stock News Now